Fas/Fas ligand-mediated death pathway is involved in oxLDL-induced apoptosis in vascular smooth muscle cells

被引:71
|
作者
Lee, TS [1 ]
Chau, LY [1 ]
机构
[1] Acad Sinica, Inst Biomed Sci, Div Cardiovasc Res, Taipei 11529, Taiwan
来源
关键词
atherosclerosis; oxysterols; p53; caspase; oxidized low-density lipoprotein;
D O I
10.1152/ajpcell.2001.280.3.C709
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Oxidized low-density lipoprotein (oxLDL) is a potent inducer of apoptosis for vascular cells. In the present study, we demonstrate that the expression of death mediators, including p53, Fas, and Fas ligand (FasL) was substantially upregulated by oxLDL in cultured vascular smooth muscle cells (SMCs). The induction of these death mediators was time dependent and was accompanied by an increase in apoptotic death of SMCs following oxLDL treatment. Two oxysterols, 7 beta -hydroxycholesterol and 25-hydroxycholesterol, were also effective to induce the expression of death mediators and apoptosis. alpha -Tocopherol and deferoxamine significantly attenuated the induction of death mediators and cell death induced by oxLDL and oxysterols, suggesting that reactive oxygen species are involved in triggering the apoptotic event. Incubation of cells with FasL-neutralizing antibody inhibited the oxLDL-induced cell death up to 50%. Furthermore, caspase 8 and caspase 3 activities were induced time dependently in SMCs following oxLDL treatment. Collectively, these data suggest that the Fas/FasL death pathway is activated and responsible for, at least in part, the apoptotic death in vascular SMCs upon exposure to oxLDL.
引用
收藏
页码:C709 / C718
页数:10
相关论文
共 50 条
  • [1] Fas/Fas ligand-mediated apoptosis of murine Langerhans cells
    Kawamura, T
    Azuma, M
    Kayagaki, N
    Shimada, S
    Yagita, H
    Okumura, K
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2000, 22 (02) : 96 - 101
  • [2] Vascular endothelial cells and smooth muscle cells differ in their expression of fas and fas ligand and in their sensitivity to fas ligand-induced cell death
    Sata, M
    Walsh, K
    CIRCULATION, 1999, 100 (18) : 485 - 485
  • [3] S-Nitrosylation of the Death Receptor Fas Promotes Fas Ligand-Mediated Apoptosis in Cancer Cells
    Leon-Bollotte, Lissbeth
    Subramaniam, Selvakumar
    Cauvard, Olivier
    Plenchette-Colas, Stephanie
    Paul, Catherine
    Godard, Cindy
    Martinez-Ruiz, Antonio
    Legembre, Patrick
    Jeannin, Jean-Francois
    Bettaieb, Ali
    GASTROENTEROLOGY, 2011, 140 (07) : 2009 - U242
  • [4] p53 and Fas/Fas ligand (FasL) dependent pathways are involved in oxidized low-density lipoprotein (oxLDL)-induced apoptosis in vascular smooth muscle cells (VSMCs).
    Chau, LY
    Lee, TS
    FASEB JOURNAL, 2000, 14 (04): : A121 - A121
  • [5] Fas/Fas ligand-mediated apoptosis as a mechanism of immune privilege
    Ferguson, TA
    Griffith, TS
    FASEB JOURNAL, 1996, 10 (06): : 1588 - 1588
  • [6] Apoptosis of vascular smooth muscle cells is induced by Fas ligand derived from endothelial cells
    Imanishi, T
    Hano, T
    Nishio, I
    Han, DKM
    Schwartz, SM
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 2001, 65 (06): : 556 - 560
  • [7] Vascular endothelial cells and smooth muscle cells differ in expression of Fas and Fas ligand and in sensitivity to Fas ligand-induced cell death - Implications for vascular disease and therapy
    Sata, M
    Suhara, T
    Walsh, K
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (02) : 309 - 316
  • [8] Role of Fas/Fas ligand-mediated apoptosis in murine contact hypersensitivity
    Xu, BH
    Bulfone-Paus, S
    Aoyama, K
    Yu, S
    Huang, PX
    Morimoto, K
    Matsushita, T
    Takeuchi, T
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2003, 3 (07) : 927 - 938
  • [9] The Fas/Fas Ligand Apoptotic Pathway Is Involved in Abrin-Induced Apoptosis
    Saxena, Nandita
    Yadav, Preeti
    Kumar, Om
    TOXICOLOGICAL SCIENCES, 2013, 135 (01) : 103 - 118
  • [10] Apoptosis of vascular smooth muscle cells is induced by Fas ligand derived from monocytes/macrophage
    Imanishi, T
    Han, DKM
    Hofstra, L
    Hano, T
    Nishio, I
    Liles, WC
    Gorden, AM
    Schwartz, SA
    ATHEROSCLEROSIS, 2002, 161 (01) : 143 - 151